Unknown

Dataset Information

0

DNMT3B overexpression downregulates genes with CpG islands, common motifs, and transcription factor binding sites that interact with DNMT3B.


ABSTRACT: DNA methylation is a key epigenetic modification to regulate gene expression in mammalian cells. Abnormal DNA methylation in gene promoters is common across human cancer types. DNMT3B is the main de novo methyltransferase enhanced in several primary tumors. How de novo methylation is established in genes related to cancer is poorly understood. CpG islands (CGIs), common sequences, and transcription factors (TFs) that interact with DNMT3B have been associated with abnormal de novo methylation. We initially identified cis elements associated with DNA methylation to investigate the contribution of DNMT3B overexpression to the deregulation of its possible target genes in an epithelial cell model. In a set of downregulated genes (n = 146) from HaCaT cells with DNMT3B overexpression, we found CGI, common sequences, and TFs Binding Sites that interact with DNMT3B (we called them P-down-3B). PPL1, VAV3, IRF1, and BRAF are P-down-3B genes that are downregulated and increased their methylation in DNMT3B presence. Together these findings suggest that methylated promoters aberrantly have some cis elements that could conduce de novo methylation by DNMT3B.

SUBMITTER: Loaeza-Loaeza J 

PROVIDER: S-EPMC9718745 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

DNMT3B overexpression downregulates genes with CpG islands, common motifs, and transcription factor binding sites that interact with DNMT3B.

Loaeza-Loaeza Jaqueline J   Cerecedo-Castillo Angel Josué AJ   Rodríguez-Ruiz Hugo Alberto HA   Castro-Coronel Yaneth Y   Del Moral-Hernández Oscar O   Recillas-Targa Félix F   Hernández-Sotelo Daniel D  

Scientific reports 20221202 1


DNA methylation is a key epigenetic modification to regulate gene expression in mammalian cells. Abnormal DNA methylation in gene promoters is common across human cancer types. DNMT3B is the main de novo methyltransferase enhanced in several primary tumors. How de novo methylation is established in genes related to cancer is poorly understood. CpG islands (CGIs), common sequences, and transcription factors (TFs) that interact with DNMT3B have been associated with abnormal de novo methylation. We  ...[more]

Similar Datasets

| S-EPMC9223787 | biostudies-literature
| S-EPMC2824720 | biostudies-literature
| S-EPMC7470969 | biostudies-literature
| S-EPMC7222804 | biostudies-literature
| S-EPMC310670 | biostudies-literature
| S-EPMC4417305 | biostudies-literature
2014-10-12 | GSE53962 | GEO